Renal Cell Cancer Metastatic Clinical Trial
Official title:
The Efficacy and Safety of CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma: a Randomized, Double-blind, Double Dummy, Multicenter Study
This randomized, double blind, phase 2/3 study is aimed to evaluate the efficacy and safety of CM082 in combination with everolimus in Chinese patients with advanced renal cell carcinoma. The primary endpoint is progression-free survival.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03634540 -
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
|
Phase 2 | |
| Terminated |
NCT01702909 -
Interleukin-2 in Metastatic Kidney Cancer
|
Phase 2 | |
| Completed |
NCT04368546 -
Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)
|
||
| Recruiting |
NCT04903873 -
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06264479 -
Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
|
||
| Terminated |
NCT03876925 -
A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
|
Phase 1/Phase 2 | |
| Completed |
NCT01658813 -
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT05326620 -
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
|
||
| Completed |
NCT04749602 -
Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
|
Phase 2 |